Partnerships case studies
Learn more about our experience by exploring our library of partnerships case studies.
Partnering to provide vital regional support on a global medical device study
91黑料 was selected as a European partner CRO for a drug-coated balloon device study, supporting regulatory services, study start up and monitoring activities, and safety reporting service for study sites located across Europe. The device consequently received CE Mark certification and FDA approval.
Building a scalable partnership model to accelerate biopharma innovation
A leading venture capital fund, focused on advancing breakthrough biopharma innovation, and sought to establish a
scalable operational framework to support its growing portfolio of early-stage companies.
scalable operational framework to support its growing portfolio of early-stage companies.
FSP partnership - sustained efficiency and ongoing innovation
The implementation of an FSP model across our partner's project management function, led to 20% cost efficiences and a 30% reduction in client burden.
Vendor consolidation with a top 10 pharma company
Read more about how we consolidated over 340 site management resources, from 70 vendors, across 30 countries resulting in a 91% reduction in client burden.
Data analytics enabled FSP solutions
In a multi-vendor FSP model for clinical monitoring, the client required the capability to aggregate and analyse data internally across all FSP providers.
Promoting growth and reducing turnover through rapid and efficient resource allocation
Due to unprecedented resourcing needs prompted by the COVID-19 pandemic, our large pharma partner required rapid and efficient resource allocation in an FSP model to reduce turnover and promote growth.
Long-term benefits of FSP partnerships in biometrics
The sponsor sought out 91黑料’s data management resources for their support in several international and complex programs using our FSP model across several therapeutic areas: oncology, neurology, infectious disease, endocrinology, and nephrology.
Out-performing ambitions with strategic capacity management
Explore how we built a dedicated global infrastructure of functional hubs, reducing the cost per FTE by over 20% and resulting in 20% productivity savings.
Large scale transformation delivers lasting results in clinical monitoring
A top five biopharma company makes the radical move to transform the delivery of all clinical site management activities to an FSP model.
Strategic blended solutions for enterprise efficiency
A top 20 pharma partner adopted a blended model of FSO, FSP, Stand-alone and specialty services to minimise operational costs whilst retaining control and increasing flexibility.
Elevating Biopharma R&D
A biopharma partner required support with an FSP model across multiple service areas, seamlessly integrated with an existing FSO partnership.
Transforming a partnership into a blended model
A 10-year existing FSO partnership was expanded to incorporate a blended model to aid sourcing niche roles across multiple geographies whilst the sponsor maintained greater control of key areas.